ACERAGEN
Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.
ACERAGEN
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2021-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.aceragen.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
IPv6 Person Schema Gravatar Profiles Akamai Hosted
Similar Organizations
Auxesia Orion
Intelligent therapeutic management for patients with orphan and rare diseases
Crozet BioPharma LLC
Crozet BioPharma LLC is a developer of biological products that prevent or treat important human diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Entest BioMedical
Entest BioMedical develops immuno-therapeutic treatments that address illnesses and maladies in both veterinary and human medicine.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Fairhaven Pharmaceuticals
Fairhaven Pharmaceuticals is a developer of oral therapeutics intended to treat severe inflammatory conditions.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Newormics
Newormics is a developer of the first high-throughput, high-content drug screening platforms.
Pattern Pharma
Pattern Pharma develops novel therapeutics that use the innate immune system to fight cancer and infectious disease.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-02 | Arrevus | Arrevus acquired by Aceragen | N/A |
| 2021-05-03 | Enzyvant Sciences | Enzyvant Sciences acquired by Aceragen | N/A |
Investors List
Novaquest Capital Management
Novaquest Capital Management investment in Private Equity Round - Aceragen
Official Site Inspections
http://www.aceragen.com Semrush global rank: 4.59 M Semrush visits lastest month: 2.1 K
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Aceragen"
Our Work - ACERAGEN
Aceragen is actively reviewing opportunities to expand our product portfolio in rare and/or genetic disorders. Please contact us if you have a program that you would like us to review for …See details»
Team - ACERAGEN
John is Aceragen’s Chief Financial Officer, having held the same role at Idera Pharmaceuticals since 2019 and transitioning to the Aceragen team as part of the 2022 merger between the …See details»
Aceragen - Crunchbase Company Profile & Funding
Organization. Aceragen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases. …See details»
Aceragen, Inc. - AnnualReports.com
Aceragen is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. Their lead product candidate, ACG …See details»
Aceragen - LinkedIn
Aceragen | 1,751 followers on LinkedIn. Aceragen is a rare disease company striving to restore a better life for patients and families. | Aceragen is a rare disease biopharmaceutical company. …See details»
Corporate Governance - Aceragen, Inc.
Aceragen is committed to maintaining the highest legal and ethical standards in every dimension of its business. Assuring compliance to these standards is of the utmost importance to the …See details»
Aceragen (Acquired) Company Profile 2025: Valuation, Investors ...
Aceragen (Acquired) General Information Description. Operator of a rare disease biopharmaceutical company focused on developing novel therapies which can have a positive …See details»
Aceragen - Funding, Financials, Valuation & Investors - Crunchbase
Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much …See details»
SEC Filings - Aceragen, Inc.
Aug 28, 2023 Please direct all questions regarding Aceragen to: Aceragen, Inc. 15 TW Alexander Drive Durham, NC 27709 [email protected]. Print Page RSS Feeds Email Alerts. …See details»
Aceragen Company Profile - Office Locations, Competitors ... - Craft
Aceragen (formerly known as Idera Pharmaceuticals) is a clinical-stage biopharmaceutical company developing a novel therapeutic approach for the treatment of genetically defined …See details»
Aceragen - Contacts, Employees, Board Members, Advisors
Organization. Aceragen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Contacts 5. ... Aceragen …See details»
Patients And Families - ACERAGEN
The needs of patients who suffer from unserved or under-served rare diseases drive our mission at Aceragen. Our goals We seek to understand the unique experiences of patients, families, …See details»
Idera Pharmaceuticals Announces Organizational Update
Apr 18, 2017 Antisense Pioneer and Idera Founder Dr. Sudhir Agrawal Set to Retire. CAMBRIDGE, Mass. and EXTON, Pa., April 18, 2017 (GLOBE NEWSWIRE) -- Idera …See details»
Aceragen - Products, Competitors, Financials, Employees, …
Aceragen is a biopharmaceutical company focused on developing therapies for rare and orphan diseases. The company's main offerings include treatments for conditions such as Farber …See details»
Idera Pharmaceuticals Acquires Aceragen – ACERAGEN
Sep 28, 2022 Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024 Conference call and …See details»
John Taylor | Board Member | Aceragen, Inc.
Prior to Aceragen, Mr. Taylor co-founded and was President and CEO of Spyryx Biosciences, a company he spun out of UNC-Chapel Hill to develop inhaled peptides as a treatment for cystic …See details»
Working at Aceragen - Glassdoor
Glassdoor gives you an inside look at what it's like to work at Aceragen, including salaries, reviews, office photos, and more. This is the Aceragen company profile. All content is posted …See details»
Our Mission - ACERAGEN
Aceragen is a rare disease biopharmaceutical company. We address rare, orphan diseases that typically have no available treatment, and strive to develop novel therapies which can have a …See details»
ACG-801 (Farber Disease) - ACERAGEN
Aceragen is engaged in the clinical development of ACG-801, recombinant human acid ceramidase. ACG-801 is an investigational enzyme replacement therapy for the treatment of …See details»